Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing facility in Virgonagar, Bengaluru, India ...

Cipla's product portfolio spans complex generics as well as drugs in the respiratory anti-retroviral urology cardiology anti-infective CNS and various other key therapeutic segments. With a rich ...

Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...

hot r&b songs the week’s most popular current r&b songs across all genres, ranked by streaming activity data by online music sources tracked by luminate, radio airplay audience impressions as ...

Cipla is currently trading at Rs 1470.55, reflecting a notable increase of 2.35% today, with 1-day returns at 2.03%. Cipla is currently valued at Rs 1466.00, marking a 2.04% rise today. The one-year ...

Cipla finished the day at Rs 1436.8, showing a fall of 0.85% in its market value. Cipla's stock is priced at Rs 1436.85, reflecting a decrease of 0.85% for the day, while the 1-day returns stand at -1 ...

Shares of Cipla Ltd. fell as much as 2% on Monday after the Mumbai-based drug manufacturer informed the exchanges that its manufacturing facility in Bengaluru's Virgonagar has received a Voluntary ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Budget 2025 has introduced a potentially game-changing tax arbitrage for unit-linked insurance policies and endowment plans sold in Gift City. But it appears this tax benefit applies only for NRIs ...